Surgeon's Record February 17, 2025
Over the past several years, I’ve had a front-row seat to healthcare innovation—advising startups, working with founders, and watching companies try to transform care delivery. After a while, a sort of pattern emerges: we keep following the same ineffectual playbook.
Venture capitalists are obsessed with unicorns — companies that reach billion-dollar valuations. Who can blame them? After all, big exits are the name of the game. Founder stories, mission and vision statements, grandiose conferences, and proclamations of tech-fueled disruption are means to an end.
Yet attempts to revolutionize healthcare remain…underwhelming.
Sure, there have been some notable exits — Amazon buying One Medical, Doximity going public, Teladoc vastly overpaying for Livongo. Investment and enthusiasm ebb and flow...
Today's Sponsors
Today's Sponsor